13F Data
13F filer · CIK 1704132

Foresite Capital Management IV, LLC

WEST HOLLYWOOD, CA · filing since Q4 2017 · last filing Aug 14, 2026
Reported value
$290.2M
+$53.1M vs prior
Positions
6
New / sold out
1 / 3
Added / reduced
2 / 0
Turnover
10.7%
buys $28.3M · sells $29.1M
Top-10 weight
100.0%

Biggest buys vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
AddedCYTOKINETICS INC+211,400+42.0%+$18.0M
NewCrinetics Pharmaceuticals, Inc.+150,000–+$5.6M
AddedRelay Therapeutics, Inc.+250,000+25.0%+$4.7M

Biggest sells vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
Sold outLyell Immunopharma, Inc.-800,399-100.0%$-16.1M
Sold outAlector, Inc.-3,887,200-100.0%$-8.4M
Sold outMaze Therapeutics, Inc.-156,901-100.0%$-4.7M

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2017: $142.7MQ1 2018: $241.2MQ2 2018: $293.4MQ3 2018: $305.0MQ4 2018: $217.9MQ1 2019: $278.3MQ2 2019: $353.8MQ3 2019: $309.4MQ4 2019: $231.8MQ1 2020: $81.1MQ2 2020: $205.3MQ3 2020: $443.4MQ4 2020: $920.6MQ1 2021: $834.8MQ2 2021: $739.8MQ3 2021: $679.1MQ4 2021: $486.0MQ1 2022: $357.4MQ2 2022: $371.4MQ3 2022: $311.0MQ4 2022: $234.1MQ1 2023: $192.7MQ2 2023: $203.4MQ3 2023: $180.0MQ4 2023: $197.9MQ1 2024: $197.9MQ2 2024: $148.8MQ3 2024: $153.0MQ4 2024: $108.8MQ1 2025: $111.1MQ2 2025: $123.8MQ3 2025: $182.6MQ4 2025: $229.7MQ1 2026: $237.1MQ2 2026: $290.2M
Q4 2017Q2 2026

Holdings · Q2 2026

#SecuritySharesValueWeight
1Pharvaris N.V.COM4,778,581$165.2M56.95%
2CYTOKINETICS INCCOM714,695$60.9M20.98%
3Eikon Therapeutics, Inc.COM1,943,682$25.4M8.74%
4Relay Therapeutics, Inc.COM1,250,000$23.4M8.06%
5Xenon Pharmaceuticals Inc.COM160,000$9.7M3.33%
6Crinetics Pharmaceuticals, Inc.COM150,000$5.6M1.93%